Annual Report

Overview

The report covers fiscal 2015, when the Nippon Shinyaku Group recorded a fourth consecutive year of growth in net sales, ordinary income, and net income. It highlights U.S. approval and launch of selexipag, followed by European marketing authorization in 2016, alongside development of treatments for intractable and rare diseases. Environmental disclosures report lower energy consumption and CO2 emissions than in fiscal 1990 and describe waste-reduction and environmental-management activities.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2015-2016
Period: 1 April 2015 – 31 March 2016
Language: English
Pages
File size
Restatement: Disclosed

Standards

Other

Materiality

Assessment
Basis

Assurance

Statement included

Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services